Select a Sector or Industry
Debt to Equity Ratio Rankings for Drug Manufacturers - Other Industry
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Rank | Symbol | Company |
Debt to Equity Ratio
|
Pro Rating
|
|---|---|---|---|---|
| 1 | POZN | Pozen | 0.00 | Go Pro |
| 1 | MSHL | Marshall Edwards | 0.00 | Go Pro |
| 1 | DRRX | Durect Corporation | 0.00 | Go Pro |
| 1 | ALXA | Alexza Pharmaceuticals | 0.00 | Go Pro |
| 1 | SOMX | Somaxon Pharmaceuticals | 0.00 | Go Pro |
| 1 | DVAX | Dynavax Technologies Corporation | 0.00 | Go Pro |
| 1 | PCYC | Pharmacyclics | 0.00 | Go Pro |
| 1 | MDCO | The Medicines Company | 0.00 | Go Pro |
| 1 | FRX | Forest Laboratories | 0.00 | Go Pro |
| 1 | DEPO | Depomed | 0.00 | Go Pro |
| 1 | ALTH | Allos Therapeutics | 0.00 | Go Pro |
| 1 | PTIE | Pain Therapeutics | 0.00 | Go Pro |
| 1 | NBY | NovaBay Pharmaceuticals | 0.00 | Go Pro |
| 1 | DUSA | DUSA Pharmaceuticals | 0.00 | Go Pro |
| 1 | BIOD | Biodel | 0.00 | Go Pro |
| 1 | OREX | Orexigen Therapeutics | 0.00 | Go Pro |
| 1 | MAPP | MAP Pharmaceuticals | 0.00 | Go Pro |
| 18 | RDEA | Ardea Biosciences | 0.0014 | Go Pro |
| 19 | SCLN | SciClone Pharmaceuticals | 0.0157 | Go Pro |
| 20 | NVO | Novo Nordisk | 0.0276 | Go Pro |
| 21 | LCI | Lannett Company | 0.0677 | Go Pro |
| 22 | TARO | Taro Pharmaceutical Industries | 0.0782 | Go Pro |
| 23 | TPI | Tianyin Pharmaceutical | 0.0822 | Go Pro |
| 24 | PTX | Pernix Therapeutics | 0.1085 | Go Pro |
| 25 | GENT | Gentium | 0.1177 | Go Pro |
| 26 | TELK | Telik | 0.1909 | Go Pro |
| 27 | UTHR | United Therapeutics Corporation | 0.2617 | Go Pro |
| 28 | AGN | Allergan | 0.2924 | Go Pro |
| 29 | SCR | Simcere Pharmaceutical Group | 0.372 | Go Pro |
| 30 | RDY | Dr. Reddy's Laboratories | 0.7418 | Go Pro |
| 31 | CBST | Cubist Pharmaceuticals | 0.7954 | Go Pro |
| 32 | APRI | Nexmed | 0.8358 | Go Pro |
| 33 | CRME | Cardiome Pharma Corporation | 0.9889 | Go Pro |
| 34 | ISIS | Isis Pharmaceuticals | 0.996 | Go Pro |
| 35 | SCMP | Sucampo Pharmaceuticals | 1.656 | Go Pro |
| 36 | ENDP | Endo Health Solutions | 1.692 | Go Pro |
| 37 | WCRX | Warner Chilcott | 20.64 | Go Pro |
